Search
Filter Results
Displaying 281–290 of 732 for “Visions 2020”
-
Mar 21, 2012
The Importance of Stem Cells (a guest post from Dr. David Gamm)
Dr. David Gamm on the potential of stem cell research to benefit patients with retinal degenerations.
-
Jan 26, 2011
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
-
May 17, 2022
AGTC’s XLRP Gene Therapy Performs Well in Extension of Phase 2 Clinical Trial
The three-month results support the planned launch of the company’s Phase 2/3 Vista trial
-
Oct 25, 2021
FDA Approves Genentech’s Susvimo for Treating Wet AMD
The approach significantly reduces the need for regular ocular injections.
-
May 3, 2021
ARVO 2021 Highlight: Update on Clinical Trial of jCyte’s Cellular Therapy for RP
Cellular treatment provided significant improvements in visual acuity for subpopulation of patients with better vision
-
Dec 7, 2020
Penn Vet’s William Beltran Elected to the National Academy of Medicine
The veterinary researcher’s canine studies are advancing promising retinal therapies toward clinical trials
-
Oct 28, 2020
-
Accessibility Statement & Guidelines
The Foundation Fighting Blindness is committed to providing communications that are accessible to the widest possible audience. With this goal in mind, our website is designed to Web Content Accessibility Guidelines (WCAG) 2.1 standards, an international standard that exceeds United States Federal Section accessibility 508 standards.
-
Jul 30, 2020
Researchers Identify Regions in the Retina to Target Therapies for Certain RP Patients
University of Pennsylvania investigators studied retinas of patients and canines with retinitis pigmentosa caused by mild mutations in RHO
-
May 21, 2020
Nacuity’s Emerging Anti-Oxidative Therapy Moves into Clinical Trial
The oral treatment shows promise for slowing vision loss in people with RP and Usher syndrome, regardless of genetic profile